ADVOCACY
-
All About HealthPartners
Readers of the Canadian Hemophilia Society (CHS) annual reports may have observed references emphasizing the significance of HealthPartners to the CHS. But what exactly is...
-
A chance to attend the WFH 2026 World Congress
Two distinct fellowships will be offered by the CHS to allow community members to attend the upcoming World Federation of Hemophilia World Congress taking place...
-
The Remarkable History of Hemophilia Care in Canada – a must-read!
Drawing on over fifty years of experience, DR. ROBERT T. CARD and DR. MAN-CHIU POON combine first-hand insights with interviews from more than seventy health care...
-
Gene therapy for hemophilia B one step closer: CSL Behring and pCPA agree on pricing
MONTREAL, October 7, 2025 – CSL Behring Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) have announced signing of a Letter of Intent that sets pricing...
-
Update on novel therapies for hemophilia A and B
MONTRÉAL, September 19, 2025 – No announcements have been made over the summer on progress in gaining access to two novel hemophilia therapies. Altuviiio for...